NEW YORK, Jan. 31, 2025 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Paragon 28, Inc. (NYSE: FNA) and its board of directors concerning the proposed ...

and 5th metatarsal hook plates; and silverback plating systems. Receive News & Ratings for Paragon 28 Daily - Enter your email address below to receive a concise daily summary of the latest news ...

and 5th metatarsal hook plates; and silverback plating systems. Receive News & Ratings for Paragon 28 Daily - Enter your email address below to receive a concise daily summary of the latest news ...

Paragon 28 Inc is a medical devices company that develops, distributes, and sells medical devices in the foot and ankle segment of the orthopedic implant marketplace. Its products include plates ...

Paragon 28, Inc. FNA shares ended the last trading session 8.3% higher at $12.99. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session.

Fintel reports that on January 29, 2025, Needham downgraded their outlook for Paragon 28 (NYSE:FNA) from Buy to Hold. Analyst Price Forecast Suggests 12.46% Upside As of January 29, 2025 ...

Bengaluru: Zimmer Biomet said on Tuesday it would acquire medical device company Paragon 28 for about $1.1 billion to expand its portfolio of orthopedic surgical devices. The deal will give Zimmer ...

Analyst Price Forecast Suggests 21.83% Upside As of January 29, 2025, the average one-year price target for Paragon 28 is $14.62/share. The forecasts range from a low of $12.12 to a high of $21.00.